Shen Lian Biomedical(688098.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Shen Lian Biomedical
688098.SH
Shanghai Shen Lian Biomedical Corporation engages in the research, development, production, and sale of veterinary biological products in China. It develops synthetic peptide vaccines to treat foot-and-mouth diseases. The company was founded in 2001 and is headquartered in Shanghai, China.
2.788 T
688098.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking153/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE-1.37%D
    • Profit Margin-7.06%D
    • Gross Margin63.25%A
  • Growth ScoreD
    • Revenue YoY-7.47%D
    • Net Profit YoY57.84%B
    • Total Assets YoY-1.97%D
    • Net Assets YoY-1.64%D
  • Cash ScoreE
    • Cash Flow Margin-112.27%E
    • OCF YoY-7.47%D
  • Operating ScoreD
    • Turnover0.18D
  • Debt ScoreA
    • Gearing Ratio8.71%A

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Shen Lian Biomedical released its performance for the first three quarters, with a net profit attributable to the parent company of 280,000 yuan, turning a profit compared to the same period last year

    Zhitong·
    SH
    688098
    -1.88%
    Zhitong·
    SH
    688098
    -1.88%

    Shen Lian Biomedical: UBI plans to reduce its holdings by no more than 3% of shares

    Zhitong·
    SH
    688098
    -1.88%
    Zhitong·
    SH
    688098
    -1.88%

    Innovative drug concept stocks continue to be active, HUAPONT LIFE SCIENCES hits the limit up

    Zhitong·
    SZ
    300683
    -3.29%
    SZ
    002004
    -1.88%
    SH
    688098
    -1.88%
    Zhitong·
    SZ
    300683
    -3.29%
    SZ
    002004
    -1.88%
    SH
    688098
    -1.88%

    Shen Lian Biomedical has been approved for a veterinary drug product approval number

    Zhitong·
    SH
    688098
    -1.88%
    Zhitong·
    SH
    688098
    -1.88%

    Shen Lian Biomedical: The Phase II clinical study of the innovative drug UB-221 injection has completed the enrollment of all subjects

    Zhitong·
    SH
    688098
    -1.88%
    Zhitong·
    SH
    688098
    -1.88%
    © 2026 Longbridge｜Disclaimer